| Style | Citing Format |
|---|---|
| MLA | Ghavami SB, et al.. "Serological Response to Sars-Cov-2 Is Attenuated in Patients With Inflammatory Bowel Disease and Can Affect Immunization." JGH Open, vol. 6, no. 4, 2022, pp. 266-269. |
| APA | Ghavami SB, Shahrokh S, Asadzadeh Aghdaei H, Khoramjoo SM, Farmani M, Kazemifard N, Parigi TL, Danese S, Balaii H, Sherkat G, Ebrahimi Daryani N, Alborzi F, Vossoughinia H, Zali MR (2022). Serological Response to Sars-Cov-2 Is Attenuated in Patients With Inflammatory Bowel Disease and Can Affect Immunization. JGH Open, 6(4), 266-269. |
| Chicago | Ghavami SB, Shahrokh S, Asadzadeh Aghdaei H, Khoramjoo SM, Farmani M, Kazemifard N, Parigi TL, et al.. "Serological Response to Sars-Cov-2 Is Attenuated in Patients With Inflammatory Bowel Disease and Can Affect Immunization." JGH Open 6, no. 4 (2022): 266-269. |
| Harvard | Ghavami SB et al. (2022) 'Serological Response to Sars-Cov-2 Is Attenuated in Patients With Inflammatory Bowel Disease and Can Affect Immunization', JGH Open, 6(4), pp. 266-269. |
| Vancouver | Ghavami SB, Shahrokh S, Asadzadeh Aghdaei H, Khoramjoo SM, Farmani M, Kazemifard N, et al.. Serological Response to Sars-Cov-2 Is Attenuated in Patients With Inflammatory Bowel Disease and Can Affect Immunization. JGH Open. 2022;6(4):266-269. |
| BibTex | @article{ author = {Ghavami SB and Shahrokh S and Asadzadeh Aghdaei H and Khoramjoo SM and Farmani M and Kazemifard N and Parigi TL and Danese S and Balaii H and Sherkat G and Ebrahimi Daryani N and Alborzi F and Vossoughinia H and Zali MR}, title = {Serological Response to Sars-Cov-2 Is Attenuated in Patients With Inflammatory Bowel Disease and Can Affect Immunization}, journal = {JGH Open}, volume = {6}, number = {4}, pages = {266-269}, year = {2022} } |
| RIS | TY - JOUR AU - Ghavami SB AU - Shahrokh S AU - Asadzadeh Aghdaei H AU - Khoramjoo SM AU - Farmani M AU - Kazemifard N AU - Parigi TL AU - Danese S AU - Balaii H AU - Sherkat G AU - Ebrahimi Daryani N AU - Alborzi F AU - Vossoughinia H AU - Zali MR TI - Serological Response to Sars-Cov-2 Is Attenuated in Patients With Inflammatory Bowel Disease and Can Affect Immunization JO - JGH Open VL - 6 IS - 4 SP - 266 EP - 269 PY - 2022 ER - |